MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Combination of Xeloda And Taxol Metastatic Breast Cancer

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Combination of Xeloda And Taxol Metastatic Breast Cancer

Combination of Xeloda And Taxol Metastatic Breast Cancer
Combination of Xeloda and Taxol is an effective therapy for women with metastatic breast cancer. New research from US Oncology Network and the University of North Carolina has recently reported that the combination of Xeloda (capecitabine) and Taxol is an effective and tolerable regimen for initial therapy of women with metastatic breast cancer. Women who were HER-2 negative were not included in the study. This is a phase II study and it is reported in the latest issue of the Journal of Clinical Oncology.

In this study the scientists reviewed 55 patients who were newly diagnosed metastatic breast cancer. These patients received oral Xeloda and weekly Taxol. Patients who had HER-2 positive tumors were not included in the study.

No patient had a complete response, however percent; of patients achieved a partial response. When stable disease is also taken into account 65 percent of patients derived benefit for the therapy. On average the response lasted for 10 months and median survival was 17 months.

From these findings the scientists have concluded that Xeloda plus Taxol is an effective, well-tolerated, and fairly convenient therapy combination as initial treatment for women with metastatic breast cancer.

Posted by: Janet




Did you know?
Combination of Xeloda and Taxol is an effective therapy for women with metastatic breast cancer. New research from US Oncology Network and the University of North Carolina has recently reported that the combination of Xeloda (capecitabine) and Taxol is an effective and tolerable regimen for initial therapy of women with metastatic breast cancer. Women who were HER-2 negative were not included in the study. This is a phase II study and it is reported in the latest issue of the Journal of Clinical Oncology.

Medicineworld.org: Combination of Xeloda And Taxol Metastatic Breast Cancer

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.